Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Abrahamson

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Clinical Genetics|July 28, 1999
An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation (C240F)U Ekström, M Abrahamson, C H Florén, et al.
American Journal of Human Genetics|October 27, 1997
Analysis of the RPGR gene in 11 pedigrees with the retinitis pigmentosa type 3 genotype: paucity of mutations in the coding region but splice defects in two familiesR Fujita, M Buraczynska, L Gieser, et al.
International Journal of Cancer|October 3, 1999
Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin CS Coulibaly, H Schwihla, M Abrahamson, et al.
Journal of Molecular Biology|August 15, 1997
NMR structural studies of human cystatin C dimers and monomersI Ekiel, M Abrahamson, D B Fulton, et al.
The Journal of Biological Chemistry|April 18, 1997
Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatinsJ Ni, M Abrahamson, M Zhang, et al.
British Journal of Haematology|September 1, 1996
A randomized study of VAD therapy with either concurrent or maintenance interferon in patients with newly diagnosed multiple myelomaG M Abrahamson, J M Bird, A C Newland, et al.
The Journal of Biological Chemistry|November 14, 2000
Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely routeV Stoka, B Turk, S L Schendel, et al.
Science (New York, N.Y.)|October 9, 2010
Areawide suppression of European corn borer with Bt maize reaps savings to non-Bt maize growersW D Hutchison, E C Burkness, P D Mitchell, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Clinical Genetics|July 28, 1999
An individual with a healthy phenotype in spite of a pathogenic LDL receptor mutation (C240F)U Ekström, M Abrahamson, C H Florén, et al.
American Journal of Human Genetics|October 27, 1997
Analysis of the RPGR gene in 11 pedigrees with the retinitis pigmentosa type 3 genotype: paucity of mutations in the coding region but splice defects in two familiesR Fujita, M Buraczynska, L Gieser, et al.
International Journal of Cancer|October 3, 1999
Modulation of invasive properties of murine squamous carcinoma cells by heterologous expression of cathepsin B and cystatin CS Coulibaly, H Schwihla, M Abrahamson, et al.
Journal of Molecular Biology|August 15, 1997
NMR structural studies of human cystatin C dimers and monomersI Ekiel, M Abrahamson, D B Fulton, et al.
The Journal of Biological Chemistry|April 18, 1997
Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatinsJ Ni, M Abrahamson, M Zhang, et al.
British Journal of Haematology|September 1, 1996
A randomized study of VAD therapy with either concurrent or maintenance interferon in patients with newly diagnosed multiple myelomaG M Abrahamson, J M Bird, A C Newland, et al.
The Journal of Biological Chemistry|November 14, 2000
Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely routeV Stoka, B Turk, S L Schendel, et al.
Science (New York, N.Y.)|October 9, 2010
Areawide suppression of European corn borer with Bt maize reaps savings to non-Bt maize growersW D Hutchison, E C Burkness, P D Mitchell, et al.
Pageof 12